CDT Equity Inc. (Nasdaq: CDT, CDTTW) 2025 Annual Report – Key Investor Highlights

Overview

CDT Equity Inc., formerly known as Conduit Pharmaceuticals Inc. and Murphy Canyon Acquisition Corp., filed its Form 10-K for the fiscal year ended December 31, 2025. The company operates in the pharmaceutical preparations sector and is listed on the Nasdaq Stock Market LLC with the trading symbols CDT for its common stock and CDTTW for its redeemable warrants.

Key Points from the Annual Report

• Reverse Stock Splits:
  CDT Equity Inc. executed four significant reverse stock splits throughout 2025 and early 2026:
  • 1-for-100 on January 24, 2025
  • 1-for-15 on May 19, 2025
  • 1-for-8 on October 10, 2025
  • 1-for-25 on March 26, 2026

  Each reverse split reduced the number of outstanding shares correspondingly. All share counts and per-share data in this report are retroactively adjusted to reflect these splits. This is highly price-sensitive as reverse splits often impact liquidity, trading dynamics, and perceived value.

• Shares Outstanding and Public Float:
  As of April 15, 2026, CDT Equity Inc. reported 4,858,417 shares outstanding with a par value of \$0.0001 per share. The aggregate market value of shares held by non-affiliates as of June 30, 2025, was \$552.00. This remarkably low public float valuation could signal limited trading activity and potentially heightened volatility.
• Security Registration:
  • Common Stock: Par value \$0.0001 per share, trading symbol CDT.
  • Redeemable Warrants: Each whole warrant exercisable for one share of common stock, trading symbol CDTTW.

  Both securities are registered on Nasdaq.

• Issuer Status:
  CDT Equity Inc. is not a well-known seasoned issuer, not a voluntary filer, and is classified as a non-accelerated filer, smaller reporting company, and emerging growth company. The company has elected not to use the extended transition period for new accounting standards.
• Compliance & Internal Controls:
  The company is current in its SEC reporting and interactive data requirements. It has not filed a Sarbanes-Oxley Section 404(b) attestation report, reflecting its status as a smaller reporting company.
• Correction of Financial Statements:
  No corrections or restatements for errors were made in 2025, and no recovery analysis was required for incentive-based compensation.
• Shell Company Status:
  CDT Equity Inc. is not considered a shell company under SEC rules.

Potentially Price-Sensitive Information

• Reverse Stock Splits: The four reverse stock splits in a short period are critical for investors. Such actions can affect share liquidity, create volatility, and may indicate underlying concerns about compliance with Nasdaq listing standards or efforts to attract new investors. Reverse splits can sometimes precede material corporate actions such as mergers, acquisitions, or recapitalizations.
• Low Public Float: The reported \$552.00 public float is unusually low, suggesting limited shares available for trading by non-affiliates. This low float can lead to outsized price swings, and investors should be aware of the risks of thinly traded stocks.
• Emerging Growth & Smaller Reporting Company: CDT’s status means it may have reduced disclosure requirements and fewer internal controls. This can impact transparency and regulatory risk, which investors should factor into their valuation models.
• Warrants Outstanding: The presence of redeemable warrants (CDTTW) alongside common shares increases potential dilution risk, which could impact future share value if warrants are exercised.

Additional Investor Considerations

• Corporate Structure Changes: The company underwent several name changes and restructuring events, reflecting a dynamic corporate history.
• SEC Reporting Compliance: CDT Equity Inc. is in compliance with all required SEC reports and data filings.
• Legal and Business Risks: Investors should reference Item 1A (Risk Factors) and Item 3 (Legal Proceedings) for detailed risk disclosures, which start on page 26 and 52 respectively, for potential risks that could materially affect business operations and share price.

Conclusion

The 2025 annual report for CDT Equity Inc. contains several important disclosures that investors should carefully review. The company’s multiple reverse stock splits, unusually low public float, and dual security structure (common shares and redeemable warrants) are all potentially price-sensitive factors. These developments could influence liquidity, volatility, and future corporate actions. Investors are strongly advised to monitor further company announcements and to conduct additional due diligence on the company’s financials, risks, and operational outlook.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should review the full SEC filings and consult with a financial advisor before making any investment decisions. The author has made every effort to accurately summarize key points from the CDT Equity Inc. 10-K filing, but cannot guarantee completeness or accuracy. Market conditions and company circumstances may change, affecting the relevance of this information.

View CDT Equity Inc. Historical chart here